Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01823172 · ClinicalTrials.gov registry record · NA
Second Echelon Node Study With Methylene Blue
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT01823172: Completed NA study, sponsored by Mayo Clinic.
NCT01823172 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01823172, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The investigators plan to study the ability to identify the lymph nodes beyond the sentinel lymph node that may harbor cancer using methylene blue dye.
Interventions
- PROCEDURE Methylene blue dye injection of sentinel lymph node
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2013-04 |
| Est. Completion | 2013-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01823172
The ClinicalTrials.gov registry entry for NCT01823172 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Methylene blue dye injection of sentinel lymph node is the first listed.
NCT01823172 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01823172 about?
NCT01823172 is a clinical study titled "Second Echelon Node Study With Methylene Blue". The investigators plan to study the ability to identify the lymph nodes beyond the sentinel lymph node that may harbor cancer using methylene blue dye.
What is the current status of trial NCT01823172?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2013-04. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01823172?
The interventions under investigation include: Methylene blue dye injection of sentinel lymph node (PROCEDURE).
Who is sponsoring clinical trial NCT01823172?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.